Premium
Dopamine agonists and impulse control disorders in Parkinson's disease
Author(s) -
MacMahon Douglas G,
Macphee Graeme JA
Publication year - 2008
Publication title -
progress in neurology and psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.19
H-Index - 12
eISSN - 1931-227X
pISSN - 1367-7543
DOI - 10.1002/pnp.100
Subject(s) - impulse control , parkinson's disease , dopamine agonist , dopamine , medicine , disease , agonist , impulse control disorder , impulse (physics) , neuroscience , psychiatry , physical medicine and rehabilitation , psychology , dopaminergic , receptor , pathological , physics , quantum mechanics
This issue of Progress features two case reports of patients who developed impulse control disorders following treatment with a dopamine agonist for Parkinson's disease, each with serious and lasting consequences. Here, Dr MacMahon and Dr Macphee shed more light on this group of medication‐related disorders, the risk factors for their development and management strategies for both prevention and treatment. Copyright © 2008 Wiley Interface Ltd